Article Text
Abstract
The risk of transmission of HIV or hepatitis B from infectious health care workers to patients is low. However, inadvertent exposure causes great concern amongst patients of an infected health care worker.
The patients of a Scottish dentist diagnosed hepatitis B e antigen positive were informed by letter of their exposure. A sample of patients was sent a postal questionnaire. Most (56%) respondents reported feeling anxious on receiving the letter but almost all (93%) thought patients should always be informed following treatment by an infectious health care worker, although the risk was very small.
We discuss clinical and ethical factors relating to informing patients following exposure to an infectious health care worker. We suggest that a balance should be struck between patients' wishes to know of risks to which they have been exposed, however small, and the professional view that when risks are negligible, patients need not be informed.
- Disease transmission - professional to patient
- health personnel
- dentists
- patient information
- truth disclosure
- hepatitis B
- HIV
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Cross-sectional hospital-based study on the seroprevalence of hepatitis B virus markers among healthcare workers, NWR, Cameroon
- Preventing and treating hepatitis B infection
- Management of chronic hepatitis B infection
- Hepatitis B virus, hepatitis C virus and other blood-borne infections in healthcare workers: guidelines for prevention and management in industrialised countries
- Cumulative viral evolutionary changes in chronic hepatitis B virus infection precedes hepatitis B e antigen seroconversion
- Hepatitis B and C in the Armed Forces
- Quantitative polymerase chain reaction assay for serum hepatitis B virus DNA as a predictive factor for post-treatment relapse after lamivudine induced hepatitis B e antigen loss or seroconversion
- Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D
- Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years
- Long-term serological, virological and histological responses to RNA inhibition by ARC-520 in Chinese chronic hepatitis B patients on entecavir treatment